Edwards Lifesciences director awarded 3,251 RSUs
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Davis Leslie C. reported acquisition or exercise transactions in this Form 4 filing.
Edwards Lifesciences Corp director Leslie C. Davis received a grant of 3,251 shares of common stock on May 8, 2026, reported as a stock award at no purchase price. The award was made under the 2020 Nonemployee Directors Stock Incentive Program and represents restricted stock units.
These units are scheduled to become 100% vested after the earlier of one year from the grant date or the company’s next annual meeting of stockholders. Following this grant, Davis directly holds a total of 9,834 shares of Edwards Lifesciences common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,251 | $0.00 | $0.00 |
Footnotes (1)
- F1. These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.
Key Figures
Key Terms
restricted stock units financial
2020 Nonemployee Directors Stock Incentive Program financial
vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Edwards Lifesciences (EW) report for Leslie C. Davis?
What are the vesting terms of the Edwards Lifesciences (EW) RSUs granted to Leslie C. Davis?
Under which plan were the Edwards Lifesciences (EW) RSUs to Leslie C. Davis granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.